HH
JAZZ icon

Hilltop Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hilltop Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,138
Closed -$200K – 345
2015
Q2 		$200K Buy
+1,138
New +$204K 0.05% 304
2014
Q2 		– Sell
-1,853
Closed -$257K – 228
2014
Q1 		$257K Sell
1,853
-485
-21% -$73K 0.13% 184
2013
Q4 		$296K Buy
2,338
+115
+5% +$11.9K 0.15% 164
2013
Q3 		$204K Buy
+2,223
New +$179K 0.12% 192

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hilltop Holdings's JAZZ Position: Q3 2015 in Review

Hilltop Holdings sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 1,138 shares — an estimated $200K sold.

Hilltop Holdings first reported a position in JAZZ in Q3 2013 and held it in 4 quarters. The position peaked at $296K in Q4 2013. 360 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • Hilltop Holdings reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Hilltop Holdings sold 1,138 Jazz Pharmaceuticals shares in Q3 2015, an estimated $200K.
  • Hilltop Holdings first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Hilltop Holdings's Jazz Pharmaceuticals position peaked at $296K in Q4 2013.
  • 360 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Hilltop Holdings's 13F filing for Q3 2015, filed 16 Nov 2015.